• Kisunla: New FDA-Approved Alzheimer's Drug Explained

  • Jul 10 2024
  • Length: 20 mins
  • Podcast

Kisunla: New FDA-Approved Alzheimer's Drug Explained

Listen for free

View show details

  • Summary

  • On this special episode we’re discussing the new FDA-approved drug Kisunla (donanemab) for the treatment of people living with early symptomatic Alzheimer’s disease. We’re joined by Dr. Margarita Reyes, a physician at Bristol Health Group in Connecticut, who explains how Kisunla works, the difference between Kisunla and Leqembi, side effects, and much more.

    Need assistance? Call the Alzheimer’s Association 24/7 Helpline (800.272.3900).
    Show more Show less
activate_primeday_promo_in_buybox_DT
Hygiene & Healthy Living
Show more Show less

What listeners say about Kisunla: New FDA-Approved Alzheimer's Drug Explained

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available